Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the iPROFILER platform
Open Access
- 1 June 2021
- journal article
- Published by Elsevier BV in Immuno-Oncology and Technology
Abstract
No abstract availableFunding Information
- NIH
- Swiss National Science Foundation
- Promedica foundation
This publication has 22 references indexed in Scilit:
- An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancerNature Medicine, 2021
- A decade of immune-checkpoint inhibitors in cancer therapyNature Communications, 2020
- The future of cancer immunotherapy: microenvironment-targeting combinationsCell Research, 2020
- Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung CancerThe New England Journal of Medicine, 2019
- Trends in clinical development for PD-1/PD-L1 inhibitorsNature Reviews Drug Discovery, 2019
- Tumour-intrinsic resistance to immune checkpoint blockadeNature Reviews Immunology, 2019
- Precision immunoprofiling by image analysis and artificial intelligenceVirchows Archiv, 2018
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell CarcinomaThe New England Journal of Medicine, 2018
- Cancer immunotherapy using checkpoint blockadeScience, 2018
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaThe New England Journal of Medicine, 2017